Cardiac events after allo-HCT in patients with acute myeloid leukemia.

Autor: Salas MQ; Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Cascos E; Cardiology Department at Hospital Clinic de Barcelona, Barcelona, Spain., López-García A; Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Pérez E; Hematology Department, Complejo Asistencial Universitario de Salamanca/Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Baile-González M; Hematology Department, Complejo Asistencial Universitario de Salamanca/Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Martín Rodríguez C; Hematology Department, Complejo Asistencial Universitario de Salamanca/Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Pascual Cascón MJ; Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain., Luque M; Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain., Esquirol A; Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Heras Fernando I; Hematology Department, Hospital General Universitario Morales Meseguer, Murcia, Spain., Peña-Muñóz F; Hematology Department, Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain., Oiartzabal Ormtegi I; Hematology Department, Hospital Universitario Donostia, Donostia, Spain., Sáez Marín AJ; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Fernández-Luis S; Hematology Department, Hospital Universitario Marques de Valdecilla (Instituto de Investigación Sanitaria Valdecilla), Santander, Spain., Domínguez-García JJ; Hematology Department, Hospital Universitario Marques de Valdecilla (Instituto de Investigación Sanitaria Valdecilla), Santander, Spain., Villar Fernández S; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain., Fernández de Sanmamed Girón M; Cardiology Department at Hospital Universitario de Gran Canaria Doctor Negrín, Gran Canaria, Spain., González Pinedo L; Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Gran Canaria, Spain., García L; Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain., González-Rodríguez AP; Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Torrado T; Hematology Department, Hospital Universitario de A Coruña, A Coruña, Spain., Filaferro S; Hematology Department, Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular, Madrid, Spain., Cedillo Á; Hematology Department, Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular, Madrid, Spain., Ortí G; Hematology Department, Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular, Madrid, Spain.; Hematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Jurado Chacón M; Hematology Department, Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular, Madrid, Spain.; Hematology Department, Hospital Universitario Virgen de las Nieves de Granada, Granada, Spain.

Publikováno v: Blood advances [Blood Adv] 2024 Nov 12; Vol. 8 (21), pp. 5497-5509.

Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study.

Autor: Muñoz-González JI; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Álvarez-Twose I; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla La Mancha and CIBERONC, Virgen del Valle Hospital, Toledo, Spain., Jara-Acevedo M; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Sequencing Service-Nucleus Platform, CIBERONC, University of Salamanca and IBSAL, Salamanca, Spain., Zanotti R; Section of Hematology, Department of Medicine, Verona University Hospital, Verona, Italy., Perkins C; Division of Hematology, Department of Medicine, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, CA, USA., Jawhar M; Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Sperr WR; Department of Internal Medicine I, Division of Hematology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Shoumariyeh K; Department of Medicine I, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium Partner Site Freiburg and German Cancer Research Center, Heidelberg, Germany., Schwaab J; Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Greiner G; Department of Laboratory Medicine and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Henriques A; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla La Mancha and CIBERONC, Virgen del Valle Hospital, Toledo, Spain., Caldas C; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Fernández-Giménez C; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Sánchez-Muñoz L; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla La Mancha and CIBERONC, Virgen del Valle Hospital, Toledo, Spain., Mayado A; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Pérez-Pons A; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Schmitt-Graeff A; Albert Ludwig University of Freiburg, Freiburg, Germany., Duyster J; Department of Medicine I, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium Partner Site Freiburg and German Cancer Research Center, Heidelberg, Germany., Tanasi I; Section of Hematology, Department of Medicine, Verona University Hospital, Verona, Italy., Olivieri F; Allergy Unit, Verona University Hospital, Verona, Italy., Mora-Casterá E; Hospital Universitario y Politécnico de la Fe, Valencia, Spain., Luna I; Hospital Universitario y Politécnico de la Fe, Valencia, Spain., Senent L; Hospital Universitario y Politécnico de la Fe, Valencia, Spain., Bañas MH; Hospital San Pedro Alcantara, Cáceres, Spain., Nuñez-García A; Hospital Virgen de las Nieves, Granada, Spain., Jurado-Chacón M; Genomic Oncology Area, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain; Instituto de Investigación Biosanitaria de Granada, Complejo Hospitales Universitarios de Granada, Universidad de Granada, Granada, Spain., Martín-Sánchez G; Hospital Universitario Marqués de Valdecilla, Santander, Spain., Colado E; Hospital Universitario Central de Asturias, Oviedo, Spain., Xicoy B; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain; Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona., Gener-Ricós G; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain; Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona., Gotlib J; Division of Hematology, Department of Medicine, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, CA, USA., Bonadonna P; Allergy Unit, Verona University Hospital, Verona, Italy., Reiter A; Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Valent P; Department of Internal Medicine I, Division of Hematology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., García-Montero AC; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain., Orfao A; Cancer Research Center-IBMCC-USAL-CSIC, Department of Medicine and Cytometry Service-Nucleus Platform, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain. Electronic address: orfao@usal.es.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2021 Mar; Vol. 8 (3), pp. e194-e204. Date of Electronic Publication: 2021 Jan 25.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.